Veru Inc (VERU)
0.6294
+0.01
(+2.31%)
USD |
NASDAQ |
Nov 14, 16:00
0.6294
0.00 (0.00%)
After-Hours: 20:00
Veru Enterprise Value: 70.47M for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 70.47M |
| November 12, 2024 | 76.88M |
| November 11, 2024 | 86.16M |
| November 08, 2024 | 87.59M |
| November 07, 2024 | 87.79M |
| November 06, 2024 | 89.22M |
| November 05, 2024 | 88.91M |
| November 04, 2024 | 87.81M |
| November 01, 2024 | 92.18M |
| October 31, 2024 | 90.98M |
| October 30, 2024 | 92.51M |
| October 29, 2024 | 97.43M |
| October 28, 2024 | 103.39M |
| October 25, 2024 | 102.23M |
| October 24, 2024 | 104.02M |
| October 23, 2024 | 108.43M |
| October 22, 2024 | 115.09M |
| October 21, 2024 | 107.99M |
| October 18, 2024 | 104.03M |
| October 17, 2024 | 106.96M |
| October 16, 2024 | 113.75M |
| October 15, 2024 | 114.27M |
| October 14, 2024 | 116.89M |
| October 11, 2024 | 107.20M |
| October 10, 2024 | 101.21M |
| Date | Value |
|---|---|
| October 09, 2024 | 113.68M |
| October 08, 2024 | 102.20M |
| October 07, 2024 | 98.30M |
| October 04, 2024 | 93.11M |
| October 03, 2024 | 90.79M |
| October 02, 2024 | 90.74M |
| October 01, 2024 | 92.56M |
| September 30, 2024 | 92.98M |
| September 27, 2024 | 93.54M |
| September 26, 2024 | 94.01M |
| September 25, 2024 | 94.05M |
| September 24, 2024 | 96.61M |
| September 23, 2024 | 94.31M |
| September 20, 2024 | 94.56M |
| September 19, 2024 | 97.70M |
| September 18, 2024 | 93.13M |
| September 17, 2024 | 95.05M |
| September 16, 2024 | 99.33M |
| September 13, 2024 | 101.34M |
| September 12, 2024 | 102.63M |
| September 11, 2024 | 107.46M |
| September 10, 2024 | 108.21M |
| September 09, 2024 | 107.74M |
| September 06, 2024 | 104.58M |
| September 05, 2024 | 108.63M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
23.29M
Minimum
Jan 19 2024
1.820B
Maximum
Aug 17 2022
366.39M
Average
237.83M
Median
Enterprise Value Benchmarks
| Regeneron Pharmaceuticals Inc | 80.57B |
| Scholar Rock Holding Corp | 2.051B |
| Keros Therapeutics Inc | 2.024B |
| Biohaven Ltd | 4.199B |
| Bioage Labs Inc | 475.77M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -10.97M |
| Revenue (Quarterly) | 3.954M |
| Total Expenses (Quarterly) | 15.00M |
| EPS Diluted (Quarterly) | -0.07 |
| Gross Profit Margin (Quarterly) | 33.84% |
| Profit Margin (Quarterly) | -277.4% |
| Earnings Yield | -47.66% |
| Normalized Earnings Yield | -50.71 |